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During 2008–2009 in Israel, equine encephalosis virus 
(EEV) caused febrile outbreaks in horses. Phylogenetic 
analysis of segment 10 of the virus strains showed that they 
form a new cluster; analysis of segment 2 showed ≈92% 
sequence identity to EEV-3, the reference isolate. Thus, the 
source of this emerging EEV remains uncertain. 
E
quine encephalosis is an arthropod-borne, 
noncontagious, febrile disease of horses. It was 
ﬁ  rst described >100 years ago by A. Theiler (1) under 
the name equine ephemeral fever. The disease is caused 
by  Equine encephalosis virus (EEV; genus Orbivirus: 
subfamily Sedoreovirinae: family Reoviridae) (2,3), which 
is transmitted by Culicoides spp. biting midges (4). Before 
2008, EEV had been isolated only in South Africa, where 
7 antigenically distinct serotypes, EEV-1–7, have been 
identiﬁ  ed and characterized (3).
Orbiviruses encode at least 7 structural and 4 
nonstructural (NS) proteins from 10 linear dsRNA genome 
segments (5). The smallest genome segment, segment 10 
(Seg-10), encodes NS3, which mediates the release of 
virus particles from infected cells, and NS3A. The second 
largest of the EEV genome segments, Seg-2, encodes virus 
protein (VP) 2, the larger of the 2 outer-capsid proteins. By 
analogy with bluetongue virus (BTV), the Orbivirus type 
species, the virus serotype is determined by the speciﬁ  city 
of interactions between VP2 and neutralizing antibodies 
generated during infection of the mammalian host. 
Consequently, VP2 and Seg-2 show sequence variations 
that correlate with serotype and, thus, can be used to 
determine the virus serotype (6).
 From October 2008 through January 2009, a febrile 
horse disease that was diagnosed as equine encephalosis 
was observed in dozens of stables across Israel (7). The 
recent emergence of novel orbivirus strains (including 
BTV and epizootic hemorrhagic disease virus) in Europe, 
North America, Asia, and Australia (8) is of major concern 
to the worldwide livestock industry. Furthermore, the 
similarity of EEV to African horse sickness virus, one 
of the most devastating pathogens of equids, warranted 
further investigation of the outbreaks and molecular 
characterization of the virus. The molecular and sequence 
analyses reported here conﬁ  rm the existence of EEV in 
Israel and identify the virus and its serotype, as well as its 
phylogenetic roots.
The Study
During October–November 2009, samples of 
whole blood from 8 febrile horses (H1–8; temperatures 
39.5°C–42°C) in Israel were collected into EDTA tubes 
and analyzed at the Koret School of Veterinary Medicine 
(Hebrew University, Rehovot, Israel). Vero cell (American 
Type Culture Collection, Manassas, VA, USA) culture 
results of blood from H3, H5, and H8 were positive for 
EEV (Table 1; Figure 1).
Total RNA was extracted from the ﬁ   fth and sixth 
passages of all 3 samples by using the QIAamp Viral RNA 
Mini Kit (QIAGEN, Valencia, CA, USA) to obtain sufﬁ  cient 
viral load for the subsequent analyses and replications. 
RNA was reverse transcribed into cDNA by using the 
Verso cDNA Kit (Thermo Fisher Scientiﬁ  c, Epsom, UK). 
PCR ampliﬁ  cation of the gene encoding NS3 (Seg-10) was 
performed on the 3 isolates by using GoTaq Green Master 
Mix (Promega, Madison, WI, USA) with the following 
primers: 5′-1GTT AAG TTT CTG CGC CAT GT23-3′, 5′-
741GTA ACA CGT TTC CGC CAC G760-3′. Thermal cycling 
conditions for the PCR were as previously described (9); the 
primer annealing temperature was modiﬁ  ed to 53.5°C. PCR 
products were puriﬁ  ed by using a cDNA puriﬁ  cation kit 
(ExoSAP-IT; USB, Cleveland, OH, USA), and sequencing 
was conducted by BigDye terminator cycle sequencing 
chemistry (Applied Biosystems, Foster City, CA, USA) 
in an ABI 3700 DNA Analyzer (Applied Biosystems) by 
using ABI data collection and sequence analysis software. 
Further analysis of the NS3 sequence was performed with 
Sequencer software, version 4.8 (Gene Codes Corp., Ann 
Arbor, MI, USA). Sequences were deposited in GenBank 
under accession nos. HQ441245 for H5, HQ441246 for 
H3, and HQ441247 for H8. The NS3 genes (Seg-10) were 
compared with those of different EEVs (9) and other related 
orbiviruses (Table 2). Phylogenic trees were generated 
by using the neighbor-joining and maximum-likelihood 
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Program; J. Felsenstein, University of Washington, Seattle, 
WA, USA) to create 100 datasets (bootstrapping) and the 
DNA Maximum Likelihood Program version 3.5 (http://
cmgm.stanford.edu/phylip/dnaml.html) to construct the 
trees. Finally, the Consense program version 3.5c (http://
cmgm.stanford.edu/phylip/consense.html) was used to 
create a ﬁ  nal consensus tree for our dataset. Broadhaven 
virus, a tick-borne orbivirus, was used as the outgroup in 
the phylogram for the gene encoding NS3. 
The phylogenetic analyses of EEV Seg-10 grouped 
the Israeli isolates with other EEV isolates but as a distinct 
group with no close relation to African horse sickness virus, 
BTV, or epizootic hemorrhagic disease virus. Within the 
EEV group, 3 discrete clusters (A, B, C) were recognized; 
the Israeli isolates formed one of these clusters (C; Figure 
2). The Israeli isolates have 85%–86% nt identity to cluster 
A and 75%–76% nt identity to cluster B.
In addition, full-length cDNA copies of individual 
EEV (from H3 and H8) genome segments were synthesized 
and ampliﬁ  ed by reverse transcription PCR by using the 
anchor spacer–ligation method as described (10,11). Partial 
sequences (for the upstream 450 bp) of Seg-2 from the 
different Israeli isolates were identical, showing 92.3% nt 
and 95.7% aa sequence identity with Seg-2 and VP2 of the 
Kaalplaas isolate, the reference isolate of EEV-3 (GenBank 
accession numbers are listed in Table 2). Previous 
phylogenetic comparisons of Seg-2/VP2 from different 
BTV types showed a maximum of 71% nt and 78% aa acid 
identity between serotypes (6), indicating that the isolates 
from Israel also belong to EEV type 3.
Conclusions
Equine encephalosis virus has long been enzootic to 
southern Africa, but it has not been isolated in other parts of 
the world. We report the characterization of an EEV strain 
isolated outside of Africa. Phylogenetic analysis of Seg-2 
showed 92% sequence identity to EEV-3 (Kaalplaas).
Analysis of Seg-10 (the gene encoding NS3) of 
different orbiviruses showed 2 clusters of South African 
EEV strains (A and B), in agreement with previously 
published studies (9). These 2 clusters appear to correlate 
with the geographic origins of the viruses in South Africa, 
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Table 1. Clinical signs for horses whose blood was tested to determine the cause of a febrile disease, Israel, October–November 2009 
Horse no.  Clinical signs 
Date of first 
clinical sign 
Duration of clinical 
signs, d 
Date of blood 
collection Virus  isolated*
1 Temperature 39.5qC, lack of appetite  Oct 25  5 Nov 2  No
2 Temperature 39.5qC, lack of appetite  Oct 29  3 Nov 2  No
3 Temperature 40qC, lack of appetite  Oct 30  3 Nov 3  Yes 
4 Temperature 39.5qC, lack of appetite  Nov 8  Unknown  Nov 8  No
5 Fever, colic, lethargy, congested mucous 
membranes, rapid pulse, lack of appetite 
Nov 5  5 Nov 9  Yes 
6 Temperature 39.5qC, lack of appetite  Nov 17  4 Nov 22  No
7 Temperature 42qC, apathy  Nov 25  2 Nov 26  No
8 Temperature 39.7qC, lack of appetite, colic  Nov 26  3 Nov 27  Yes 
*Positive cases were confirmed by reverse transcription PCR of dsRNA genome segment 10. 
Figure 1. Geographic location of farms in Israel with horses showing 
signs of equine encephalosis virus (EEV) infection. Eight horses 
with suspected EEV infection lived on 7 farms. Red circles indicate 
farms with EEV-positive cases.Equine Encephalosis Virus in Israel
independent of their isolation date. It has been suggested 
that the 2 EEV Seg-10 clusters in South Africa are related 
to the distribution of their Culicoides spp. midge vectors, 
C. imicola (senso stricto) and C. bolitinos. The former is 
the most abundant Culicoides spp. midge in Israel (12). 
However, the EEV isolates from Israel group as a distinct 
cluster (C) with similar distances to the 2 South African 
clusters, raising questions concerning the geographic 
origin of this virus. A similar ﬁ  nding has been observed in 
African horse sickness virus Seg-10, which also forms into 
3 distinct groups (13).
The question of how and when the virus was initially 
introduced to Israel remains unanswered. Because the 
clinical manifestations of equine encephalosis are usually 
mild, it is often overlooked and underdiagnosed. EEV could 
have been introduced to Israel before the virus was ﬁ  rst 
isolated in 2009. Alternatively, the virus might have been 
introduced into neighboring countries and transmitted into 
Israel by infected vectors carried by winds, as described 
for other orbiviruses (14,15). The fact that the Israeli strain 
of EEV-3 grouped in a different cluster than the 2 South 
African strains, supports the idea that it has evolved in this 
region for a sufﬁ  cient time to accumulate these changes and 
most likely was not recently introduced into Israel from 
South Africa. 
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Table 2. GenBank accession numbers for orbiviruses used for 
phylogenic analyses of strain isolated from horses in Israel, 
2009*
Virus Strain
Accession no. 
Seg-2 Seg-10 
EEV-1 (Cascara)  FLD1  AY115878 
FLD2 AY115876 
FLD3 AY115875 
FLD4 AY115877 
Ref AY115865 
Ref† AY115864 
EEV-2 (Gamil)  Ref AY115871 
EEV-3 (Kaalplaas)  FLD1  AY115874 
Ref HQ630933 AY115867 
EEV-4 (Bryanston)  Ref AY115868 
EEV-5 (Kyalami)  Ref AY115869 
EEV-6
(Potchefstroom) 
Ref AY115866 
FLD1 AY115872 
FLD2 AY115873 
EEV-7 (N Rand)  Ref AY115870 
AHSV-2 AF276700 
AHSV-4 AJ007305
AHSV-7 AJ007306
BRDV M83197 
BTV- 2  AF135224 
BTV-12 AF135227 
PALV (Chuzan)  AB018091 
EHDV-1 NC_013405.1 
EHDV-2 AM745086.1 
Israel EEV H5  Animal H5  HQ441245 
Israel EEV H3  Animal H3 
(ISR2009/20)‡ 
JF495411 HQ441246 
Israel EEV H8  Animal H8 
(ISR2009/21)‡ 
JF495412 HQ441247 
*Seg, dsRNA genome segment; EEV, equine encephalosis virus; FLD, 
field strain; ref, reference strain; N Rand, North Rand; AHSV, African 
horse sickness virus; BRDV, Broadhaven virus; BTV, bluetongue virus; 
PALV, Palyam virus; EHDV, epizootic hemorrhagic disease virus; H5, H3, 
H8, horses 5, 3, 8.  
†Unknown origin. 
‡Isolate numbers for the Orbivirus reference collection 
(www.reoviridae.org/dsRNA_virus_proteins/ReoID/EEV-isolates.htm). 
Figure 2. Phylogeny of equine encephalosis virus (EEV) segment 
10 (nonstructural protein 3 gene) isolated from horses in Israel in 
2009. The phylogenic tree was constructed by using the neighbor-
joining method and bootstrapped with 100 replicates. Branch 
lengths are indicative of the genetic distances between sequences. 
Other orbiviruses were included for reference, with Broadhaven 
virus (BRDV) selected as the outgroup. The 3 suggested EEV 
clusters are marked green (cluster A), blue (cluster B), and orange 
(cluster C, representing the isolates from Israel). FLD, ﬁ  eld strain; 
REF, reference; H3, H5, H8, horse 3, 5, and 8; EHDV, epizootic 
hemorrhagic disease virus; BTV, bluetongue virus; PALV, Palyam 
virus; AHSV, African horse sickness virus. Scale bar indicates 
nucleotide substitution per site.References
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